McKesson Analyst Ratings
JPMorgan Adjusts Price Target on McKesson to $661 From $656, Maintains Overweight Rating
Evercore Maintains McKesson(MCK.US) With Buy Rating, Maintains Target Price $630
McKesson (MCK) Receives a Buy From Evercore ISI
Argus Research Maintains McKesson(MCK.US) With Buy Rating
Analysts Conflicted on These Healthcare Names: Oric Pharmaceuticals (ORIC), Aerovate Therapeutics (AVTE) and McKesson (MCK)
Argus Research Adjusts McKesson Price Target to $640 From $670
Analysts Conflicted on These Healthcare Names: Harmony Biosciences Holdings (HRMY) and McKesson (MCK)
McKesson (MCK) Gets a Hold From Wells Fargo
Wells Fargo Adjusts Price Target on McKesson to $576 From $551
Buy Rating Affirmed for McKesson With Positive Growth Outlook Despite Minor Setbacks
Mizuho Securities Adjusts Price Target on McKesson to $570 From $540
Barclays Keeps Their Buy Rating on McKesson (MCK)
McKesson Analyst Ratings
Optimistic Buy Rating for McKesson Based on Core Growth Drivers and Positive Fiscal Outlook
Analysts Offer Insights on Healthcare Companies: McKesson (MCK), Amedisys (AMED) and Draegerwerk AG & Co. KGaA (GB:0K5E)
Jefferies Adjusts Price Target on McKesson to $670 From $620, Maintains Buy Rating
McKesson (MCK) Receives a Buy From Barclays
McKesson Analyst Ratings
Citigroup Raises Price Target on McKesson to $670 From $620, Buy Rating Maintained